Poster

Vidya Ramakrishnan, Christina Friedrich, Colleen Witt, Meghan Pryor, Michael Dolton, Jasi Atwal, Kristin Wildsmith, Katherine Kudrycki, Robert Sheehan, Seung-Hye Lee, Hans Peter Grimm, Roxana Aldea, Norman Mazer, Carsten Hofmann, Ronald Gieschke, Reina Fuji, Jin Yan Jin, Saroja Ramanujan, Angelica Quartino

A Quantitative Systems Pharmacology Model of Alzheimer’s Disease Pathology and Treatment Modalities

Presented by Genentech, Hofmann-La Roche, and Rosa at the American Conference on Pharmacometrics (ACoP), November 2020

Poster

Ronald B. Moss, Dennis J. Carlo, Christina Friedrich, Katherine Kudrycki, R. Baillie, Meghan Pryor, Mike Reed

QSP modeling predicts higher naloxone doses will safely reverse more opioid overdoses and save lives.

Presented by Adamis Pharmaceuticals and Rosa at the American Conference on Pharmacometrics (ACoP), November 2020

Poster

Christina Friedrich, Colleen Witt, Meghan Pryor, Katherine Kudrycki, Rebecca Baillie, Robert Sheehan, Michael Reed

How does mechanistic QSP modeling reduce R&D risk in data poor disease areas such as central nervous system (CNS) diseases?

Presented by Rosa at the American Conference on Pharmacometrics (ACoP), November 2020

Poster

Chris Schelling, Rick Ridgewell, Christina Friedrich, Katherine Kudrycki, Rebecca Baillie, Douglas Chung, Mike Reed

QSP modeling shows efficacy of an NK3R antagonist to reduce treatment induced vasomotor symptoms

Presented by Acer Therapeutics and Rosa at the American Conference on Pharmacometrics (ACoP), November 2020

Poster

Christina Friedrich, Rebecca Baillie, Michael Weis, Meghan Pryor, Vincent Hurez, Katherine Kudrycki, Michael Reed

Using Mechanistic Quantitative Systems Pharmacology (QSP) Models To Connect Biomarkers To Clinical Disease Activity Scores Examples In Atopic Dermatitis And Psoriasis

Presented by Rosa at the American Conference on Pharmacometrics (ACoP), November 2020

Poster

Michael Weis, Douglas Chung, Vincent Hurez, Rebecca Baillie, Katherine Kudrycki, Michael Reed

Development of a Mechanistic Model of Keratinocyte Dynamics and Skin Barrier Function for Psoriasis Research

Presented by Rosa at the American Conference on Pharmacometrics (ACoP), November 2020

Conference Presentation

Vincent Hurez

Using Mechanistic QSP Models to Connect Biomarkers to Clinical Disease Activity Scores

Presented by Rosa at the American Conference on Pharmacometrics (ACoP), November 2020

Peer Reviewed Journal Publication

Ronald B Moss, Meghan McCabe Pryor, Rebecca Baillie, Katherine Kudrycki, Christina Friedrich, Mike Reed, Dennis J Carlo

Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu receptor level

Published in PLoS One, 2020 Jun 16

"We enable our clients to learn things that would be impractical or impossible to learn from empirical studies alone."
—Mike Reed, PhD, Chief Scientist, PhysioPD
Learn more about PhysioPD